BioVie Inc.
BIVI
$1.71
-$0.04-2.29%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -17.54M | -18.99M | -24.27M | -25.56M | -32.12M |
| Total Depreciation and Amortization | 229.20K | 229.20K | 229.20K | 229.20K | 229.20K |
| Total Amortization of Deferred Charges | 11.90K | -746.80K | 52.10K | 80.40K | 108.70K |
| Total Other Non-Cash Items | 2.67M | 4.46M | 4.19M | 3.80M | 3.92M |
| Change in Net Operating Assets | -4.40M | -2.37M | -2.22M | 2.11M | -86.90K |
| Cash from Operations | -19.03M | -17.42M | -22.02M | -19.35M | -27.95M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 0.00 | 0.00 | 0.00 | 14.53M |
| Cash from Investing | -- | 0.00 | 0.00 | 0.00 | 14.53M |
| Total Debt Issued | 2.90M | 2.90M | -- | -- | -- |
| Total Debt Repaid | -5.85M | -8.35M | -10.85M | -10.00M | -10.00M |
| Issuance of Common Stock | 18.58M | 18.58M | 37.05M | 28.16M | 27.80M |
| Repurchase of Common Stock | -2.90M | -2.90M | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 12.73M | 10.23M | 26.20M | 18.16M | 17.80M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -6.30M | -7.20M | 4.18M | -1.19M | 4.38M |